52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Mar 31, 2025 Apr 15, 2025 0.0856
Apr 03, 2024 Apr 18, 2024 0.0862
Mar 31, 2023 Apr 17, 2023 0.1802

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Causeway Capital Management LLC 21,803
RhumbLine Advisers LP 429
Mar Vista Investment Partners LLC 303
TOP MUTUAL FUND HOLDERS POSITION
ActivePassive International Equity ETF 21,803

Data provided by FactSet Research Systems Inc.

Important Notice to Investors of Unsponsored DRs and GDNs:

From time to time, BNY may pay a rebate to brokers that deposit shares with BNY for the issuance of unsponsored depositary receipts (DRs) or global depositary notes. BNY assumes no obligation or responsibility, and expressly disclaims any liability arising out of, or relating to, such rebates, including without limitation whether the rebate or any portion of it is passed on to the beneficial holders by the brokers.
Unsponsored DRs may be issued by multiple depositary banks servicing a particular DR program. Consequently, as a result of Depository Trust & Clearing Corporation (“DTCC”) practice, the actual cash distribution fees charged may differ from the BNY fees detailed in the fee schedule as fees will be charged in accordance with the fee schedule of the depositary bank that is considered to be the “First Filer”. The fees to be charged for any particular unsponsored cash distribution will be disclosed on the event announcement published by the “First Filer”. BNY takes no responsibility for the level of fees charged by any other depositary bank. The “First Filer” is the depositary bank that filed the first Form F-6 for a program with the U.S. Securities and Exchange Commission (“SEC”). In the event the actual “First Filer” does not have DRs outstanding for a program, the next depositary bank who filed a
Form F-6 with the SEC and has DRs outstanding will be deemed to be the First Filer for these purposes.

DR Details

DR Symbol SOAGY
CUSIP 80385Q208
DR Venue OTC
DR ISIN US80385Q2084
Ratio DR:ORD 5:1
First Filer CIT
Underlying ISIN DE0007165631
Underlying SEDOL 5843329
Country Germany
Effective Date Nov 25, 2019
Depositary BK, CIT, JPMC (Unsponsored)
Industry Pharma. & Biotech.
Sartorius is an international pharmaceutical and laboratory equipment supplier. The Company is engaged in the provision of international laboratory and process technology for the biotech and pharmaceutical industries. The Company operations are organized along two segments: Bioprocess Solutions, which provides solutions for the core process steps in biopharmaceutical production, focusing on the areas of activity of filtration, fermentation, cell cultivation and fluid management; and Lab Products & Services, which offers laboratories in the pharmaceutical and biopharmaceutical industries as well as at academic research institutes solutions for bioanalytics and laboratory products, consumables and services.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.1000
Cancellation up to $0.1000
Cash Distribution up to $0.1000
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.1000
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 51.70 354,795 16,895
Mar.25 46.78 225,370 10,732
Feb.25 50.03 91,272 4,804

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE